By helping to accelerate the development of new treatments and changing cancer research methods, the Multiple Myeloma Research Foundation (MMRF) is dedicated to eradicating multiple myeloma, currently an incurable blood cancer. As the world’s number one private funder of multiple myeloma research, the MMRF has raised over $360 million since its inception and directs nearly 90% of its total budget to research and related programming. With its efforts, ten drugs have received FDA approval in the time it normally takes for one, and the Foundation is well-positioned to see new drug breakthroughs that will make a difference in patients lives.